Prof. Dr. Gül Başaran

2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.08.1314 Texte intégral en libre accèsSource : OpenAlex

COVID Pandemisi Sürecinde Meme Kanserinde Antihormon Tedavi

Türkiye Klinikleri COVID - 19, 2020

Source : OpenAlex

Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Cancer Research, 2020

DOI 10.1158/1538-7445.sabcs19-p5-11-19 Source : OpenAlex

Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.

Journal of Clinical Oncology, 2020

DOI 10.1200/jco.2020.38.15_suppl.e13055 Source : OpenAlex

Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak

Turkish Journal of Surgery, 2020

DOI 10.5578/turkjsurg.4815 PMID 33015560 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Yaşlı Hastalarda Meme Kanseri Tedavisine Yaklaşım

Turkiye Klinikleri Medical Oncology - Special Topics, 2020

Source : OpenAlex

APPROACH TO BREAST CANCER TREATMENT IN ELDERLY PATIENTS

Turkiye Klinikleri eBooks, 2020

DOI 10.5336/978-625-401-191-7_p77 Source : OpenAlex

Adjuvant Therapy for HER-2-Positive Early Breast Cancer

Springer eBooks, 2019

DOI 10.1007/978-3-030-16792-9_9 Source : OpenAlex

THE EFFECT OF HYPERTENSION THE TREATMENT OF DOXAZOSIN ON BENIGN PROSTATE HYPERPLASIA PATIENTS

Urology Research and Practice, 2019

Texte intégral en libre accèsSource : OpenAlex

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Cancer Chemotherapy and Pharmacology, 2018

DOI 10.1007/s00280-018-3712-7 PMID 30377778 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Annals of Oncology, 2018

DOI 10.1093/annonc/mdy272.315 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Türkiye’de Metastatik Meme Kanserinde HER2 hedefli tedavide Pertuzumab kullanımı erken dönem güvenlilik verileri

Kocaeli Üniversitesi - AVESİS, 2018

Source : OpenAlex

Türkiye’xxde metastatik meme kanserinde Her2 hedefli tedavide pertuzumab kullanımı erken dönem güvenlilik verileri

Kocaeli Üniversitesi - AVESİS, 2018

Source : OpenAlex

Türkiye'de Metastatik Meme Kanserinde HER-2 Hedefli Tedavide Pertuzumab Kullanımının Erken Dönem Güvenlik Verileri

Van Yüzüncü Yıl University Academic Data Management System, 2018

Source : OpenAlex

Gebelik ve Meme Kanseri (TOG Meme ve Genç Araştırmacılar Grubu çalışması)

Kocaeli Üniversitesi - AVESİS, 2018

Source : OpenAlex

Cost of Treatment of HR+/HER2- Post Menopausal Advanced/Metastatic Breast Cancer Patients in Turkey

Value in Health, 2016

DOI 10.1016/j.jval.2016.03.1569 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Adjuvant Therapy for HER2-Positive Early Breast Cancer

Springer eBooks, 2016

DOI 10.1007/978-3-319-26012-9_9 Source : OpenAlex

Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials

Critical Reviews in Oncology/Hematology, 2015

DOI 10.1016/j.critrevonc.2015.10.006 PMID 26603345 38 citations (Europe PMC) Source : OpenAlex

Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS).

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.15_suppl.e11589 Source : OpenAlex

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

European Journal of Cancer, 2015

DOI 10.1016/j.ejca.2015.10.012 PMID 26724641 36 citations (OpenAlex) Source : OpenAlex

Mutation analysis of the BRCA1 and BRCA2 genes in Turkish patients with breast cancer.

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.15_suppl.e12536 Source : OpenAlex

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience

Meme sağlığı dergisi/Meme sağlığı dergisi, 2014

DOI 10.5152/tjbh.2014.1904 PMID 28331673 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

Asian Pacific Journal of Cancer Prevention, 2014

DOI 10.7314/apjcp.2014.15.1.117 PMID 24528011 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.

Europe PMC (PubMed Central), 2014

PMID 24995112 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma: Single institution experience.

Journal of Clinical Oncology, 2014

DOI 10.1200/jco.2014.32.15_suppl.e19503 2 citations (OpenAlex) Source : OpenAlex

Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

Breast Cancer, 2013

DOI 10.1007/s12282-013-0506-y PMID 24338610 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

The Breast, 2013

DOI 10.1016/j.breast.2013.07.048 PMID 23954396 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Hipokalemik Paralizi ile Klinik Belirti Veren Adrenokortikal Karsinom Olgusu

Acibadem University Open Access Repository, 2013

Texte intégral en libre accèsSource : OpenAlex

349 High Ki67 Values Are Significantly Correlated with Oncotype DX Scores

European Journal of Cancer, 2012

DOI 10.1016/s0959-8049(12)70415-x Source : OpenAlex

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Journal of Clinical Oncology, 2012

DOI 10.1200/jco.2012.30.15_suppl.e16015 Texte intégral en libre accèsSource : OpenAlex

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Kocaeli Üniversitesi - AVESİS, 2012

Source : OpenAlex

Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

Biomarkers, 2012

DOI 10.3109/1354750x.2012.738250 PMID 23116493 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK).

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e12007 Texte intégral en libre accèsSource : OpenAlex

Primary breast mantle cell lymphoma with atypical relapse patterns.

PubMed, 2011

PMID 21674874 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study.

PubMed, 2011

PMID 21766495 Texte intégral en libre accèsSource : OpenAlex

The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational study.

PubMed, 2011

PMID 22331719 3 citations (Europe PMC) Source : OpenAlex

TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA.

Dspace Repository (Marmara Üniversitesi), 2011

2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e18010 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Correlation of high FDG uptake in PET/CT with poor prognosis in metastatic gastric adenocarcinoma.

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e14668 Texte intégral en libre accèsSource : OpenAlex

Clinical/pathologic characteristics of diabetic patients with early breast cancer (BC) and their survival outcome.

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e11019 Texte intégral en libre accèsSource : OpenAlex

Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.629 5 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e13079 1 citation (OpenAlex) Source : ORCID

The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients.

Journal of Clinical Oncology, 2011

DOI 10.1200/jco.2011.29.15_suppl.e11042 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey

Medical Oncology, 2010

DOI 10.1007/s12032-010-9463-x PMID 20306160 17 citations (Europe PMC) Source : OpenAlex

Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

Medical Oncology, 2010

DOI 10.1007/s12032-010-9516-1 PMID 20390469 14 citations (Europe PMC) Source : OpenAlex

498 Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities. Single center experience

European Journal of Cancer Supplements, 2010

DOI 10.1016/s1359-6349(10)70519-x Texte intégral en libre accèsSource : OpenAlex

Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Alone in Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma: Do We Really Have Robust Data?

Journal of Clinical Oncology, 2010

DOI 10.1200/jco.2010.29.0304 PMID 20606082 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

E7. Taxanes as adjuvant therapy for breast cancer

European Journal of Cancer Supplements, 2010

DOI 10.1016/s1359-6349(10)70011-2 Texte intégral en libre accèsSource : OpenAlex

Dalakta ve terminal ileumda gelişen malign melanom metastazı, cerrahi tedavi sonrası oluşan perineal metastaz: Olgu sunumu

Kocaeli Üniversitesi - AVESİS, 2010

Source : OpenAlex

A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion.

PubMed, 2009

PMID 19650184 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex